Terry-Ann Burrell
Insider Reports History
- Location
- Cambridge, MA
- Signature
- /s/ Jonathan Golightly, attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Terry-Ann Burrell:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Beam Therapeutics Inc. | Chief Financial Officer | Common Stock | 82,637 | $2,523,858 | $30.54 | 26 Apr 2024 | Direct |
| Beam Therapeutics Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 25,000 | $610,000 | $24.40 | 26 Apr 2024 | Direct |
| RECURSION PHARMACEUTICALS, INC. | Director | Class A Common Stock | 71,254 | $514,098 | $7.22 | 01 Jul 2024 | Direct |
| RECURSION PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 26,193 | 03 Jun 2024 | Direct |
Insider Reports Filed by Terry-Ann Burrell
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | 01 Jul 2024 | 1 | $0 | 4 | Director | 03 Jul 2024, 16:39 |
| RAPP | Rapport Therapeutics, Inc. | 06 Jun 2024 | 0 | $0 | 3 | Director | 06 Jun 2024, 18:52 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 03 Jun 2024 | 2 | $0 | 4 | Director | 05 Jun 2024, 18:12 |
| BEAM | Beam Therapeutics Inc. | 26 Apr 2024 | 2 | $0 | 4 | Chief Financial Officer | 29 Apr 2024, 16:10 |
| BEAM | Beam Therapeutics Inc. | 01 Apr 2024 | 1 | -$174,926 | 4 | Chief Financial Officer | 03 Apr 2024, 19:39 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 01 Apr 2024 | 1 | $0 | 4 | Director | 03 Apr 2024, 17:42 |
| BEAM | Beam Therapeutics Inc. | 31 Mar 2024 | 1 | $0 | 4 | Chief Financial Officer | 02 Apr 2024, 16:10 |
| BEAM | Beam Therapeutics Inc. | 31 Jan 2024 | 1 | +$1,342,000 | 4 | Chief Financial Officer | 02 Feb 2024, 16:05 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 12 Jul 2023 | 5 | -$1,412,414 | 4 | Director | 14 Jul 2023, 18:52 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 16 Jun 2023 | 2 | $0 | 4 | Director | 21 Jun 2023, 17:19 |
| BEAM | Beam Therapeutics Inc. | 03 Apr 2023 | 2 | -$137,978 | 4 | Chief Financial Officer | 05 Apr 2023, 20:30 |
| BEAM | Beam Therapeutics Inc. | 31 Jan 2023 | 1 | $0 | 4/A | Chief Financial Officer | 19 Apr 2023, 16:30 |
| BEAM | Beam Therapeutics Inc. | 26 Jan 2023 | 6 | -$1,169,875 | 4 | Chief Financial Officer | 30 Jan 2023, 15:05 |
| BEAM | Beam Therapeutics Inc. | 23 Jan 2023 | 6 | -$634,119 | 4 | Chief Financial Officer | 25 Jan 2023, 16:25 |
| BEAM | Beam Therapeutics Inc. | 18 Jan 2023 | 3 | -$1,584,742 | 4 | Chief Financial Officer | 20 Jan 2023, 15:18 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 17:24 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 03 Oct 2022 | 1 | $0 | 4 | Director | 05 Oct 2022, 21:12 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 01 Jul 2022 | 1 | $0 | 4 | Director | 06 Jul 2022, 17:48 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 14 Jun 2022 | 2 | $0 | 4 | Director | 16 Jun 2022, 20:12 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 01 Apr 2022 | 1 | $0 | 4 | Director | 05 Apr 2022, 19:23 |
| BEAM | Beam Therapeutics Inc. | 31 Mar 2022 | 2 | -$105,630 | 4 | CFO | 04 Apr 2022, 20:22 |
| BEAM | Beam Therapeutics Inc. | 31 Jan 2022 | 1 | $0 | 4 | CFO | 02 Feb 2022, 17:00 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 19:41 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 01 Oct 2021 | 1 | $0 | 4 | Director | 05 Oct 2021, 20:33 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 01 Jul 2021 | 1 | $0 | 4 | Director | 06 Jul 2021, 17:00 |
| BEAM | Beam Therapeutics Inc. | 30 Jun 2021 | 4 | -$3,249,600 | 4 | CFO | 02 Jul 2021, 18:01 |
| BEAM | Beam Therapeutics Inc. | 28 Jun 2021 | 9 | -$4,230,416 | 4 | CFO | 30 Jun 2021, 18:00 |